Benzinga | Oct 6, 2020 02:28PM EDT

Why Neuronetics Stock Is Trading Higher Today

Neuronetics (NASDAQ:STIM) shares are trading higher on Tuesday after BTIG reiterated a Buy rating on the stock and raised its price target from $6 to $10.

Neuronetics is a commercial-stage medical technology company. It is focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders.

Neuronetics shares traded up 13.73% to $5.88 on Tuesday. The stock has a 52-week high of $9.39 and a 52-week low of $1.25.